With the ongoing pandemic affecting in-person meetings and travel, two companies worked to bring surgeon training into the future using virtual reality (VR). Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, presented a training lab for surgeons across the country using Immertec’s proprietary VR platform Medoptic.

William Levine, MD presents the Catalyst CSR™ Total Shoulder System, including two new components, during the 2019 ASES meeting on Saturday, Oct. 19.

Catalyst OrthoScience has raised $12.7 million in an oversubscribed Series C-1 financing round led by River Cities Capital Funds.

Catalyst OrthoScience announced the publication of a peer-reviewed study in the Journal of Shoulder and Elbow Arthroplasty

Catalyst OrthoScience announced 510(k) clearance for its uncemented Press Fit humeral implant. The new humeral

Catalyst OrthoScience introduced the patent pending 3-Peg Glenoid implant to its innovative Catalyst CSR™ Total Shoulder

Catalyst OrthoScience announced the addition of Brian K. Hutchison to its board of directors as executive chair.